Geneva, Aug. 17 -- International Clinical Trials Registry received information related to the study (ChiCTR2600129636) titled 'A retrospective study on the role and mechanism of Epstein-Barr virus protein BRRF2 in inhibiting innate immunity through exosomes' on Aug. 7.
Study Type: Observational study
Study Design:
Sequential
Primary Sponsor: Sun Yat-sen University Cancer Center
Condition:
Nasopharyngeal carcinoma
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-08-07
Target Sample Size: Nasopharyngeal carcinoma observation group:27;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=307223
Published by HT Digital Content Services with permission fro...